Final word: Ignore the GLP-1 meds scaremongering and focus on the facts At the end of the day, this entire media firestorm is based on a handful of cases in people who were already at risk
For example, let's say your protocol calls for 250 mcg of BPC 157 and 250 mcg of TB 500
In general: Price should not be the only deciding factor
A stratified Cox proportional hazards model was used, with treatment as a fixed effect and trial-level cardiovascular risk as the stratification factor, to estimate hazard ratios (HRs) and confidence intervals (CIs) when comparing tirzepatide to the control
35,36 While the subsequent GUIDE-HF trial did not find a difference in cardiovascular outcomes using PA pressure monitoring, a newly published trial based out of Europe, MONITOR-HF, demonstrated findings similar to the earlier CHAMPION trial that PA pressure monitoring to guide HF management reduced HF-related hospitalizations and improved quality of life
Incretin and islet hormonal responses to fat and protein ingestion in healthy men
